Clinical study to compare long term use of Fluticasone Propionate alone to Fluticasone Propionate and Salmeterol together in Asthma patients. - Trial 2015-004867-35
Access comprehensive clinical trial information for 2015-004867-35 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research and Development Ltd. and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
GlaxoSmithKline Research and Development Ltd.
GlaxoSmithKline
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
The primary efficacy measures were the mean change from baseline at endpoint in AM PEF compared between the FSC 100/50mcg BID and MON 10mg QD treatment groups to assess superiority and compared between the FSC and FSC+MON treatment groups to assess equivalence.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2015-004867-35
Non-Device Trial